FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

GDUFA 2022 Science and Research Report

[ Price : $8.95]

FDA issues the FY 2022 GDUFA Science and Research Report with information on projects in 13 scientific areas.

Improve Biosimilar Development and Approval Efficiency

[ Price : $8.95]

Two FDAers introduce a journal issue exploring ways in which clinical pharmacology innovations can expand the development and appr...

Externally Controlled Trial Guidance

[ Price : $8.95]

FDA publishes a draft guidance with considerations for designing and conducting externally controlled trials for drug and biologic...

FDA 'Defying' Appeals Court is Troubling: Attorneys

[ Price : $8.95]

Two Epstein Becker attorneys say an FDA statement challenging the 11th Circuit Court of Appeals application of its position on orp...

CBER 2023 Guidance Agenda

[ Price : $8.95]

FDA publishes its 2023 guidance agenda listing 11 guidances it is considering developing this year.

Biden Administration Ending Public Health Emergency 5/11

[ Price : $8.95]

The Biden Administration announces that it will end the current Covid-19 public health emergency declaration and national emergenc...

CBER Tissues/Advanced Therapies Director Bryan Retiring

[ Price : $8.95]

After more than 22 years at FDA, CBER Office of Tissues and Advanced Therapies director Wilson Bryan announces he is retiring in M...

Califf Proposes Transformation of Foods Program, ORA

[ Price : $8.95]

FDA commissioner Robert Califf announces a new transformative vision for the agencys human foods program and the Office of Regulat...

2 EUAs Granted for Mpox Diagnostics

[ Price : $8.95]

Federal Register notice: FDA announces the issuance of two Emergency Use Authorizations for diagnostic devices intended for use du...

Optical Camera Software for Respiratory Measurements

[ Price : $8.95]

Federal Register notice: FDA classifies software for optical camera-based measurements of pulse rate, heart rate, breathing rate, ...